The Food and Drug Administration (FDA) is no stranger to public pressure when it comes to legalizing cannabis. Far from it, the FDA has been under pressure for decades to legalize and regulate cannabis, at least for medical use. It has resisted this pressure to date, however, it may crumble soon as the pressure it’s under grows.
Cannabis is proving to be a huge industry, with profits in the US projected to overtake fizzy soft drinks in terms of profitability by 2030. It’s not surprising that the number of countries wanting a piece of this pie is growing rapidly.
In addition to the economic benefits of legal cannabis, the scientific research that this ancient plant medicine can be of real use as a treatment for a whole range of medical conditions from cancer to epilepsy and acne to eczema is growing by the day. It’s becoming increasingly difficult for critics to dismiss this.
NORML argues that this classification doesn’t reflect the properties of the plant, and fails to consider the many health benefits that it has been proven to contain. The UN’s forbidding of cannabis was established roughly 50/40 years ago and is considered outdated by many. Prominent figures from NORML’s Board of Directors had submitted their testimony’s that said
It’s no wonder that in America public perception of cannabis is rapidly changing, as is proven by the 10 thousand people who submitted handwritten letters to the FDA. However, this shift in attitudes isn’t just taking place in the US. Across the world, many governments are legalizing cannabis for medicinal and even recreational use. And the FDA will be faced with no choice but to change how they look at cannabis if this trend continues.